Evidence map›Paper›PMID 25312384›Full record

ArticleCell host & microbe2014

Structural insight into HIV-1 restriction by MxB.

Jennifer L Fribourgh, Henry C Nguyen, Kenneth A Matreyek, Frances Joan D Alvarez, Brady J Summers, Tamaria G Dewdney, Christopher Aiken, Peijun Zhang, Alan Engelman, Yong Xiong

Open access · bronzeAbstract read
In one paragraph

Article in Cell host & microbe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. MX2 Mediates Collapse of the HIV-1 Capsid.bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cyclophilin A Regulates Tripartite Motif 5 Alpha Restriction of HIV-1.International journal of molecular sciences · 2025
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. The capsid revolution.Journal of molecular cell biology · 2024
    Review
  14. Article
  15. Article
  16. Review
  17. Capsid-host interactions for HIV-1 ingress.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  18. Article
  19. Article
  20. Review

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Jennifer L Fribourgh *Yale University, Molecular Biophysics and Biochemistry, New Haven, CT 06520, USA.
Henry C Nguyen *Yale University, Molecular Biophysics and Biochemistry, New Haven, CT 06520, USA.
Kenneth A Matreyek *Dana-Farber Cancer Institute, Department of Cancer Immunology and AIDS, Boston, MA 02215, USA.
Frances Joan D AlvarezUniversity of Pittsburgh School of Medicine, Department of Structural Biology, Pittsburgh, PA 15260, USA.
Brady J SummersYale University, Molecular Biophysics and Biochemistry, New Haven, CT 06520, USA.
Tamaria G DewdneyDana-Farber Cancer Institute, Department of Cancer Immunology and AIDS, Boston, MA 02215, USA.
Christopher AikenVanderbilt University School of Medicine, Pathology, Microbiology and Immunology, Nashville, TN 37232-263, USA.
Peijun ZhangUniversity of Pittsburgh School of Medicine, Department of Structural Biology, Pittsburgh, PA 15260, USA.
Alan EngelmanDana-Farber Cancer Institute, Department of Cancer Immunology and AIDS, Boston, MA 02215, USA.
Yong XiongYale University, Molecular Biophysics and Biochemistry, New Haven, CT 06520, USA.
Yale University · USDana-Farber Cancer Institute · USUniversity of Pittsburgh · USVanderbilt University · US

Funding

X-Ray Core P50GM082251 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI CALERO, GUILLERMO ALBERTO · 2007 to 2018
$48.1M
Skill Development for Diverse Scientific Careers: A New Course Predoctoral Program in Cellular and Molecular BiologyT32GM007223 · NIGMS · YALE UNIVERSITY · PI BASERGA, SUSAN J · 1985 to 2019
$31.0M
Nuclear Localization of HIV-1 Preintegration ComplexesR01AI052014 · NIAID · DANA-FARBER CANCER INSTITUTE · PI ENGELMAN, ALAN N. · 2003 to 2025
$11.4M
PREDOCTORAL PROGRAM IN BIOPHYSICST32GM008283 · NIGMS · YALE UNIVERSITY · PI XIONG, YONG · 1988 to 2022
$10.5M
NIAID NIH HHS AI052014NIAID NIH HHS R01 AI052014NIGMS NIH HHS GM082251NIGMS NIH HHS P50 GM082251NIGMS NIH HHS T32 GM007223NIGMS NIH HHS T32 GM008283
6 · The paper itself

Abstract

The myxovirus resistance (Mx) proteins are interferon-induced dynamin GTPases that can inhibit a variety of viruses. Recently, MxB, but not MxA, was shown to restrict HIV-1 by an unknown mechanism that likely occurs in close proximity to the host cell nucleus and involves the viral capsid. Here, we present the crystal structure of MxB and reveal determinants involved in HIV-1 restriction. MxB adopts an extended antiparallel dimer and dimerization, but not higher-ordered oligomerization, is critical for restriction. Although MxB is structurally similar to MxA, the orientation of individual domains differs between MxA and MxB, and their antiviral functions rely on separate determinants, indicating distinct mechanisms for virus inhibition. Additionally, MxB directly binds the HIV-1 capsid, and this interaction depends on dimerization and the N terminus of MxB as well as the assembled capsid lattice. These insights establish a framework for understanding the mechanism by which MxB restricts HIV-1.

Indexed as

CapsidCell Line, TumorCrystallography, X-RayGene Expression RegulationHIV-1Host-Pathogen InteractionsHumansMicroscopy, ConfocalMyxovirus Resistance ProteinsProtein ConformationProtein MultimerizationVirus AssemblyMX2 protein, humanMyxovirus Resistance Proteins

Identifiers

PMID25312384
PMCPMC4252739
OpenAlexW2039325208

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.